Mario Assenmacher

6.0k total citations · 1 hit paper
64 papers, 4.2k citations indexed

About

Mario Assenmacher is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mario Assenmacher has authored 64 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Immunology, 33 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Mario Assenmacher's work include CAR-T cell therapy research (29 papers), Immune Cell Function and Interaction (22 papers) and T-cell and B-cell Immunology (22 papers). Mario Assenmacher is often cited by papers focused on CAR-T cell therapy research (29 papers), Immune Cell Function and Interaction (22 papers) and T-cell and B-cell Immunology (22 papers). Mario Assenmacher collaborates with scholars based in Germany, United States and United Kingdom. Mario Assenmacher's co-authors include Andreas Radbruch, Jürgen Schmitz, Max Löhning, Stefan Miltenyi, Wenjun Ouyang, Kenneth M. Murphy, Alexander Scheffold, Zhiguang Gao, Sheila Ranganath and Rudi Manz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Mario Assenmacher

63 papers receiving 4.1k citations

Hit Papers

Stat6-Independent GATA-3 Autoactivation Directs IL-4-Inde... 2000 2026 2008 2017 2000 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Stat6-Independent GATA-3 Autoactivation Directs IL-4-Independent Th2 Development and Commitment
    2000 576 citations Max Löhning, Mario Assenmacher et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Assenmacher Germany 31 2.7k 1.2k 858 781 442 64 4.2k
Roger P.M. Sutmuller Netherlands 24 3.4k 1.3× 1.5k 1.2× 773 0.9× 474 0.6× 324 0.7× 30 4.5k
Matthias Schiemann Germany 35 3.1k 1.2× 1.2k 1.0× 1.1k 1.3× 675 0.9× 335 0.8× 68 4.5k
Adrian Bot United States 35 2.0k 0.7× 2.2k 1.8× 1.1k 1.3× 448 0.6× 845 1.9× 132 4.3k
Thomas Brocker Germany 38 4.2k 1.6× 1.1k 0.9× 1.1k 1.3× 404 0.5× 535 1.2× 87 5.4k
Masaki Terabe United States 42 4.7k 1.8× 2.4k 1.9× 1.6k 1.9× 650 0.8× 270 0.6× 101 6.5k
Shahram Salek‐Ardakani United States 37 2.8k 1.0× 1.1k 0.9× 848 1.0× 463 0.6× 235 0.5× 70 3.9k
Tim Worbs Germany 21 3.2k 1.2× 987 0.8× 1.0k 1.2× 274 0.4× 240 0.5× 27 4.9k
Ulrike Koehl Germany 45 3.0k 1.1× 2.9k 2.3× 1.3k 1.5× 761 1.0× 757 1.7× 155 5.6k
S. Marieke van Ham Netherlands 37 2.4k 0.9× 610 0.5× 1.1k 1.3× 618 0.8× 246 0.6× 135 4.5k
Giulia Casorati Italy 48 5.8k 2.2× 2.1k 1.7× 1.5k 1.7× 542 0.7× 843 1.9× 131 7.4k

Countries citing papers authored by Mario Assenmacher

Since Specialization
Citations

This map shows the geographic impact of Mario Assenmacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Assenmacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Assenmacher more than expected).

Fields of papers citing papers by Mario Assenmacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Assenmacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Assenmacher. The network helps show where Mario Assenmacher may publish in the future.

Co-authorship network of co-authors of Mario Assenmacher

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Assenmacher. A scholar is included among the top collaborators of Mario Assenmacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Assenmacher. Mario Assenmacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rawashdeh, Wa’el Al, Dominik Lock, Christoph Herbel, et al.. (2023). Targeting Stage-Specific Embryonic Antigen 4 (SSEA-4) in Triple Negative Breast Cancer by CAR T Cells Results in Unexpected on Target/off Tumor Toxicities in Mice. International Journal of Molecular Sciences. 24(11). 9184–9184. 7 indexed citations
2.
Borchmann, Peter, Álvaro Urbano-Ispizúa, François Lemonnier, et al.. (2023). A RANDOMIZED PHASE II STUDY OF MB‐CART2019.1 COMPARED TO STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR ASCT – DALY 2‐EU TRIAL. Hematological Oncology. 41(S2). 840–841. 3 indexed citations
3.
Kutsch, Nadine, Philipp Gödel, Udo Holtick, et al.. (2022). A Phase I Dose Finding Trial of MB-CART20.1 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Blood. 140(Supplement 1). 12980–12981. 2 indexed citations
4.
Gödel, Philipp, Hyatt Balke‐Want, Francis Ayuk, et al.. (2022). P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT. HemaSphere. 6. 1070–1071. 2 indexed citations
5.
Krueger, Winfried, André Roy, Wa’el Al Rawashdeh, et al.. (2021). Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription Factors. Cancers. 13(19). 4741–4741. 13 indexed citations
6.
Lock, Dominik, Franziska Blaeschke, Sandra Karitzky, et al.. (2021). Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells. Molecular Therapy — Methods & Clinical Development. 21. 42–53. 10 indexed citations
7.
8.
Lock, Dominik, Nadine Mockel-Tenbrinck, Daniela Mauer, et al.. (2017). Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use. Human Gene Therapy. 28(10). 914–925. 85 indexed citations
9.
Assenmacher, Mario, et al.. (2013). Multiplex and functional detection of antigen-specific human T cells by ITRA—Indirect T cell recognition assay. Journal of Immunological Methods. 404. 13–23. 3 indexed citations
10.
11.
Schmucker, Sonja, Mario Assenmacher, Jürgen Schmitz, & Anne Richter. (2008). Adoptive T Cell Therapy of Human CMV Infection in Immunocompromised Hosts: In Vitro Generation of CMV-Specific T Cells from Naive Precursors. Blood. 112(11). 206–206. 1 indexed citations
12.
Löhning, Max, Anne Richter, Jane Hu‐Li, et al.. (2003). Establishment of memory for IL-10 expression in developing T helper 2 cells requires repetitive IL-4 costimulation and does not impair proliferation. Proceedings of the National Academy of Sciences. 100(21). 12307–12312. 29 indexed citations
13.
Hu‐Li, Jane, Christophe Pannetier, Liying Guo, et al.. (2001). Regulation of Expression of IL-4 Alleles. Immunity. 14(1). 1–11. 132 indexed citations
14.
Keenan, Russell, Naeem Khan, Rachel Bruton, et al.. (2001). Purification of cytomegalovirus‐specific CD8 T cells from peripheral blood using HLA–peptide tetramers. British Journal of Haematology. 115(2). 428–434. 52 indexed citations
15.
16.
Leyendeckers, Heike, Rudolf A. Manz, Stefan Miltenyi, et al.. (1999). Enrichment and detection of live antigen-specific CD4+ and CD8+ T cells based on cytokine secretion. European Journal of Immunology. 29(12). 4053–4059. 162 indexed citations
17.
Assenmacher, Mario, Max Löhning, Alexander Scheffold, et al.. (1998). Commitment of Individual Th1-Like Lymphocytes to Expression of IFN-γ Versus IL-4 and IL-10: Selective Induction of IL-10 by Sequential Stimulation of Naive Th Cells with IL-12 and IL-4. The Journal of Immunology. 161(6). 2825–2832. 38 indexed citations
18.
Schmitz, Jürgen, Andreas Thiel, Ralf Kühn, et al.. (1994). Induction of interleukin 4 (IL-4) expression in T helper (Th) cells is not dependent on IL-4 from non-Th cells.. The Journal of Experimental Medicine. 179(4). 1349–1353. 134 indexed citations
19.
Assenmacher, Mario, Jürgen Schmitz, & Andreas Radbruch. (1994). Flow cytometric determination of cytokines in activated murine T helper lymphocytes: Expression of interleukin‐10 in interferon‐γ and in interleukin‐4‐expressing cells. European Journal of Immunology. 24(5). 1097–1101. 269 indexed citations
20.
Schmitz, Jürgen, Mario Assenmacher, & Andreas Radbruch. (1993). Regulation of T helper cell cytokine expression: functional dichotomy of antigen‐presenting cells. European Journal of Immunology. 23(1). 191–199. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roger P.M. Sutmuller Breakdown of academic impact, for papers by Matthias Schiemann Breakdown of academic impact, for papers by Adrian Bot Breakdown of academic impact, for papers by Thomas Brocker Breakdown of academic impact, for papers by Masaki Terabe Breakdown of academic impact, for papers by Shahram Salek‐Ardakani Breakdown of academic impact, for papers by Tim Worbs Breakdown of academic impact, for papers by Ulrike Koehl Breakdown of academic impact, for papers by S. Marieke van Ham Breakdown of academic impact, for papers by Giulia Casorati
Rankless by CCL
2026